NCT04447378View on ClinicalTrials.gov

Safety of Fondaparinux as Post Partum Thromboprophylaxis

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Thromboembolism in the Puerperium
Interventions
DRUG

Fondaparinux 2.5Mg/0.5Ml Inj Syr

post natal thromboprophylaxis

Trial Locations (1)

56000

Department of Obstetrics & Gynaecology, Universiti Kebangsaan Medical Centre, Cheras

All Listed Sponsors
lead

National University of Malaysia

OTHER

NCT04447378 - Safety of Fondaparinux as Post Partum Thromboprophylaxis | Biotech Hunter | Biotech Hunter